Embrace performance for detection of Clostridioides difficile infection (CDI)*

The BD MAX^TM Cdiff assay provides rapid detection of the C. difficile toxin B gene (tcdB),
the gene essential for CDI¹, including infections caused by hypervirulent strains

• CDI is the most important (preventable) infective cause of healthcare-associated diarrhoea in Europe and is associated with high morbidity and mortality²
• The BD MAX™ Cdiff assay is a real time polymerase chain reaction (PCR) assay offering diagnostic speed and accuracy to allow fast treatment decisions and prevent transmission of infection³
• Traditional diagnostic methods can be time-consuming (toxigenic culture or cell cytotoxicity neutralization assay) or may have poor sensitivity (glutamate dehydrogenase assays)^4-5
• PCR is recommended by ESCMID guidelines as a primary test in a 2-step algorithm for diagnosis of CDI²
• The BD MAX™ Cdiff assay is integrated on the fully automated BD MAX™ System and is run compatible with
  other healthcare associated infection (HAI) assays³
• Results are available in approximately 2 hours with only 1 minute of hands-on time per specimen³

Improved patient
management

Workflow
efficiency

Diagnostic
accuracy